Pacific Biosciences of California (PACB) EBITDA (2010 - 2026)
Pacific Biosciences of California (PACB) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Pacific Biosciences of California (PACB) EBITDA is -$123M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Pacific Biosciences of California (PACB) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -84.71% |
| 3 Years TTM | -26.55% |
| 5 Years TTM | +4.48% |
| 10 Years TTM | +17.41% |
| All Time TTM | +1.66% |
Annual EBITDA change of Pacific Biosciences of California (PACB)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$6.16M | -98.86% |
| 2025 | -$541M | +17.44% |
| 2024 | -$461M | +42.58% |
| 2023 | -$323M | +8.49% |
| 2022 | -$298M | +46.49% |
| 2021 | -$203M | +107.47% |
| 2020 | -$98M | +5.02% |
| 2019 | -$93M | -0.52% |
| 2018 | -$94M | +15.28% |
| 2017 | -$81M | +20.74% |
| 2016 | -$67M | +164.61% |
| 2015 | -$25M | -56.58% |
| 2014 | -$59M | -18.44% |
| 2013 | -$72M | -18.02% |
| 2012 | -$88M | -15.64% |
| 2011 | -$104M | -23.01% |
| 2010 | -$135M | +61.50% |
| 2009 | -$84M | N/A |
Comparison Pacific Biosciences of California (PACB) five years EBITDA CAGR with competitors
Pacific Biosciences of California (PACB) five years EBITDA CAGR is 4.47%.